Publication
Environmental injustice: How informal e-waste recycling impacts human rights
In light of the documentary ‘Buy Now! The Shopping Conspiracy,’ the global issue of ‘e-waste’ has become a topic of conversation in many households.
Pharma in brief - CETA tracker: Senate passes CETA Bill C-30 to implement pharmaceutical patent reform
Author:
Global | Publication | May 2017
Treaty/Act: CETA/Bill C-30 (An Act to implement the Comprehensive Economic and Trade Agreement between Canada and the European Union and its Member States and to provide for certain other measures)
Date: May 11, 2017 – Bill C-30 passes third reading in Senate
The overhaul to Canada’s pharmaceutical patent regime is nearly here. On May 11, 2017, the Canadian Senate passed Bill C-30 (the act intended to implement CETA into Canadian law) without amendment, the final major stage of the legislative process. Bill C-30 will become law once it receives royal assent, a formality.
As we reported, CETA and Bill C-30 provide key reforms to the Patent Act affecting the pharmaceutical industry, including:
- Patent term restoration capped at a maximum of two years for eligible patents covering eligible products; and
- Replacement of the current summary proceedings under the Patented Medicines (Notice of Compliance) Regulations with full actions resulting in a final determination of patent infringement and validity. Equal access to effective appeal rights will also be provided.
We anticipate the details to be published shortly.
Are you CETA ready? Contact Norton Rose Fulbright with all your CETA questions.
Links
Bill C-30, Third Reading (House of Commons)
Text of the final Comprehensive Economic and Trade Agreement
Recent publications
Publication
Legislation on default consolidation of small DC pots to be included in forthcoming Pension Schemes Bill
The DWP has confirmed that primary legislation enabling the introduction of a default consolidator model for small DC pension pots (up to £1,000) will be included in the forthcoming Pension Schemes Bill expected before Parliament’s summer recess.
Publication
Pensions Regulator publishes its first Annual Funding Statement under the new funding code
The Regulator's annual DB funding statement for 2025 was published on April 29, 2025. This statement and the accompanying analysis paper are particularly relevant to schemes with valuation dates between September 22, 2024, and September 21, 2025, now known as Tranche 24/25 or T24/25 to reflect the calendar year (previously known as Tranche 20 or T20).
Subscribe and stay up to date with the latest legal news, information and events . . .